Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 3/20 | 0.58 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | PLK1 | P53350 | 3/20 | 0.32 |
| ▸ | CRY2 | Q49AN0 | 8/20 | 0.32 |
| ▸ | PER2 | O15055 | 7/20 | 0.32 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.31 |
| ▸ | CRY1 | Q16526 | 6/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14366998 | 0.79 | CYP2C9 (0.90) | CYP2C9NR1I2MAPK1HSD17B10PLK1 | |
| SCHEMBL8239242 | 0.78 | CYP2C9 (0.71) | CYP2C9NR1I2MAPK1HSD17B10PLK1 | |
| SCHEMBL5089690 | 0.74 | CYP2C9 (1.00) | CYP2C9NR1I2MAPK1HSD17B10PLK1 | |
| SCHEMBL6690316 | 0.73 | CYP2C9 (0.83) | CYP2C9NR1I2MAPK1HSD17B10PLK1 | |
| SCHEMBL6693467 | 0.73 | CYP2C9 (0.79) | CYP2C9NR1I2MAPK1HSD17B10PLK1 | |
| SCHEMBL6693468 | 0.73 | CYP2C9 (0.81) | CYP2C9NR1I2MAPK1HSD17B10PLK1 | |
| SCHEMBL6687554 | 0.73 | CYP2C9 (0.79) | CYP2C9NR1I2MAPK1HSD17B10PLK1 | |
| SCHEMBL6232054 | 0.72 | CYP2C9 (0.80) | CYP2C9NR1I2MAPK1HSD17B10PLK1 | |
| SCHEMBL7131813 | 0.72 | CYP2C9 (0.80) | CYP2C9NR1I2MAPK1HSD17B10PLK1 | |
| SCHEMBL7077857 | 0.72 | CYP2C9 (0.78) | CYP2C9NR1I2MAPK1HSD17B10PLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007092616-A2 | COMBINATIONS COMPRISING HCV PROTEASE INHIBITOR(S) AND HCV POLYMERASE INHIBITOR(S), AND METHODS OF TREATMENT RELATED THERETO | SCHERING CORPORATION (US) | 2007-08-16 | — | — | WO | disclosed |